• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Flovent HFA (fluticasone propionate) Inhalation Aerosol

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – July 2011

 

Summary View

6 ADVERSE REACTIONS

6.2 Postmarketing Experience
  • Gastrointestinal Disorders: Dental caries and tooth discoloration